- Weill Cornell Medicine
- United States of America
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to deliver personalized marketing content and to operate, serve and track ads.
These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.
These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Your Fertility and Sterility Dialog login information is not the same as your ASRM or EES credentials. Users must create a separate account to comment or interact on the Dialog.
Register
Recent Comments
In their Reflection, Tradewell & Masterson comment on the value of FSH and testis volume to predict the chance of sperm retrieval in men with non-obstructive azoospermia, in a series published in the same journal issue by Majzoub et al. The authors of the Reflection appear to miss the concept that men with obstructive azoospermia can also be identified by the presence of normal FSH and normal testicular volume. It has been long-ago identified that azoospermic men with a testis length >4.5 cm and FSH <7.6 have a 90% chance of obstructive azoospermia (Schoor et al., 2002). Since 64% (45/70) of the men who underwent successful TESA had no histologic evaluation, but normal testis volume and normal FSH, the reviewers/Reflectioners seem to miss the obvious conclusion that most of the men with sperm retrieved by TESA likely had obstructive azoospermia rather than non-obstructive azoospermia. Indeed, of the articles which demonstrate that low FSH and normal testis volume predict sperm retrieval in NOA, most of them have very limited testis sampling and/or include men with obstruction. Mature series of effective microTESE procedures have demonstrated no adverse predictive value of elevated FSH on sperm retrieval rates (and, indeed, a trend toward lower sperm retrieval in those men with low FSH who are more likely to have diffuse maturation arrest; Ramasamy et al., 2009).
Interpretation of studies that propose preoperative predictive values in men with NOA who undergo attempted sperm retrieval must be carefully reviewed to assess for the extent of sperm search with microTESE as well as the potential contamination of the study population with men who have obstructive azoospermia. Failure to do so results in pollution of our published literature with misleading information that can ultimately lead to harm to our patients who may be given inaccurate preoperative counseling.
References:
Ramasamy R, Lin K, Gosden LV, Rosenwaks Z, Palermo GD, Schlegel PN. High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction. Fertil Steril. 2009 Aug;92(2):590-3.
Schoor RA, Elhanbly S, Niederberger CS, Ross LS. The role of testicular biopsy in the modern management of male infertility. J Urol 2002 Jan;167(1):197-200.